Liberi Group and Starodub BV have entered into a strategic consultancy agreement to deliver integrated services across the biotech and medtech sectors.
Combining Liberi’s global strengths in business development, valuation, and investment services with Starodub’s deep expertise in regulatory, quality, and manufacturing, this partnership creates a powerful offering for companies navigating early development through to global market access.
We’re thrilled about the value this collaboration will bring to clients and stakeholders across the life sciences landscape.
